Eton Pharmaceuticals CEO Sells Stock Amid Strong Market Performance and Mixed Earnings Reports
Sean Brynjelsen, President and Chief Executive Officer of Eton Pharmaceuticals, Inc., recently sold a substantial amount of the company's common stock. This transaction occurs against a backdrop of strong recent stock gains but also follows mixed first-quarter 2026 earnings reports and strategic developments regarding key drug commercialization rig…